317 related articles for article (PubMed ID: 32106819)
1. Eliminating viral hepatitis C in Belgium: the micro-elimination approach.
Busschots D; Toghanian S; Bielen R; Salomonsson S; Koc ÖM; Hendrickx G; Jadoul M; Nevens F; Sokal E; Brixko C; Peerlinck K; Apers L; Robaeys G; Lazarus JV
BMC Infect Dis; 2020 Feb; 20(1):181. PubMed ID: 32106819
[TBL] [Abstract][Full Text] [Related]
2. A micro-elimination approach to addressing hepatitis C in Turkey.
Idilman R; Razavi H; Robbins-Scott S; Akarca US; Örmeci N; Kaymakoglu S; Aygen B; Tozun N; Güner R; Bodur H; Lazarus JV
BMC Health Serv Res; 2020 Mar; 20(1):249. PubMed ID: 32209103
[TBL] [Abstract][Full Text] [Related]
3. Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
Fransen L; D'hondt P; Bielen R; Van den Ende N; Robaeys G; Peerlinck K; Nevens F
Haemophilia; 2019 Nov; 25(6):1028-1034. PubMed ID: 31469476
[TBL] [Abstract][Full Text] [Related]
4. Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Litzroth A; Suin V; Wyndham-Thomas C; Quoilin S; Muyldermans G; Vanwolleghem T; Kabamba-Mukadi B; Verburgh V; Jacques M; Van Gucht S; Hutse V
BMC Public Health; 2019 Jan; 19(1):39. PubMed ID: 30621662
[TBL] [Abstract][Full Text] [Related]
5. Australia needs to increase testing to achieve hepatitis C elimination.
Scott N; Sacks-Davis R; Wade AJ; Stoove M; Pedrana A; Doyle JS; Thompson AJ; Wilson DP; Hellard ME
Med J Aust; 2020 May; 212(8):365-370. PubMed ID: 32167586
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
7. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
[TBL] [Abstract][Full Text] [Related]
8. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
Kondili LA; Blach S; Razavi H; Craxì A
Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
[TBL] [Abstract][Full Text] [Related]
9. Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.
Lim AG; Qureshi H; Mahmood H; Hamid S; Davies CF; Trickey A; Glass N; Saeed Q; Fraser H; Walker JG; Mukandavire C; Hickman M; Martin NK; May MT; Averhoff F; Vickerman P
Int J Epidemiol; 2018 Apr; 47(2):550-560. PubMed ID: 29309592
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.
Benzaken AS; Girade R; Catapan E; Pereira GFM; Almeida EC; Vivaldini S; Fernandes N; Razavi H; Schmelzer J; Ferraz ML; Ferreira PRA; Pessoa MG; Martinelli A; Souto FJD; Walsh N; Mendes-Correa MC
Braz J Infect Dis; 2019; 23(3):182-190. PubMed ID: 31145876
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
[TBL] [Abstract][Full Text] [Related]
12. Can hepatitis C be eradicated in the United States?
Edlin BR; Winkelstein ER
Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
[TBL] [Abstract][Full Text] [Related]
13. Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach.
Busschots D; Ho E; Blach S; Nevens F; Razavi H; Van Damme B; Vanwolleghem T; Robaeys G
BMC Infect Dis; 2022 Apr; 22(1):397. PubMed ID: 35459120
[TBL] [Abstract][Full Text] [Related]
14. Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature.
Bojovic K; Simonovic-Babic J; Mijailovic Z; Milosevic I; Jovanovic M; Ruzic M; Cvejic Pasic T; Svorcan P; Petrovic M; Jordovic J
J Infect Dev Ctries; 2020 Feb; 14(2):117-124. PubMed ID: 32146444
[TBL] [Abstract][Full Text] [Related]
15. Elimination of hepatitis C in Europe: can WHO targets be achieved?
Matičič M; Lombardi A; Mondelli MU; Colombo M;
Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
17. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
18. The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination.
Busschots D; Kremer C; Koc ÖM; Heyens L; Bielen R; Apers L; Florence E; Messiaen P; Van Laethem K; Van Wijngaerden E; Nevens F; Hens N; Robaeys G
Int J Infect Dis; 2021 Apr; 105():217-223. PubMed ID: 33610786
[TBL] [Abstract][Full Text] [Related]
19. A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination.
Taye BW
Am J Trop Med Hyg; 2019 Nov; 101(5):963-972. PubMed ID: 31516107
[TBL] [Abstract][Full Text] [Related]
20. Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.
Leask JD; Dillon JF
Aliment Pharmacol Ther; 2016 Jul; 44(2):145-56. PubMed ID: 27199103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
